Guidelines for the diagnosis and therapy of adult myelodysplastic syndromes
Open Access
- 24 January 2003
- journal article
- guideline
- Published by Wiley in British Journal of Haematology
- Vol. 120 (2) , 187-200
- https://doi.org/10.1046/j.1365-2141.2003.03907.x
Abstract
No abstract availableKeywords
This publication has 78 references indexed in Scilit:
- Low‐dose melphalan induces favourable responses in elderly patients with high‐risk myelodysplastic syndromes or secondary acute myeloid leukaemiaBritish Journal of Haematology, 2000
- Poor response rate to a continuous schedule of Amifostine therapy for ‘low/intermediate risk’ myelodysplastic patientsBritish Journal of Haematology, 1998
- Prognostic factors in myelodysplastic syndromes: critical analysis of the impact of age and gender and failure to identify a very‐low‐risk group using standard mortality ratio techniquesBritish Journal of Haematology, 1996
- A good response rate to recombinant erythropoietin alone may be expected in selected myelodysplastic patients. A preliminary clinical studyEuropean Journal of Haematology, 1996
- Treatment of 34 patients with myelodysplastic syndromes with 13‐CIS retinoic acidEuropean Journal of Haematology, 1995
- The use of r‐HuEpo in the treatment of anaemia related to myelodysplasia (MDS)British Journal of Haematology, 1995
- All-Trans Retionic ACid in the Treatment of Myelodysplastic SyndromesLeukemia & Lymphoma, 1995
- Failure of combination therapy with recombinant granulocyte colony-stimulating factor and erythropoietin in myelodyspplastic syndromesAnnals of Hematology, 1994
- The evaluation of low-dose cytarabine in the treatment of myelodysplastic syndromes: A phase-III intergroup studyAnnals of Hematology, 1992
- Proposals for the classification of the myelodysplastic syndromesBritish Journal of Haematology, 1982